id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-P-0182-0017,FDA,FDA-2007-P-0182,FDA/CDER to sanofi-aventis U.S. LLC - Petition Partial Approval and Denial,Other,PPAD-Petition Partial Approval and Denial,2010-10-13T04:00:00Z,2010,10,2010-10-13T04:00:00Z,,2013-08-11T01:37:34Z,,0,0,0900006480b6e5df
FDA-2007-P-0182-0016,FDA,FDA-2007-P-0182,See FDA-2007P-0182-0017,Other,,2010-10-13T00:00:00Z,2010,10,,,2013-07-27T23:34:29Z,,0,1,0900006480b6e4c1
FDA-2007-P-0182-0014,FDA,FDA-2007-P-0182,See 2007-P-0182-0003,Other,CP-Citizen Petition,2009-08-17T04:00:00Z,2009,8,2009-08-17T04:00:00Z,,2009-08-26T17:07:15Z,,0,0,0900006480a0b5fd
FDA-2007-P-0182-0011,FDA,FDA-2007-P-0182,sanofi-aventis - Supplement,Other,SUP-Supplement,2008-10-07T04:00:00Z,2008,10,2008-10-07T04:00:00Z,,2008-10-07T21:43:20Z,,0,0,09000064806b5573
FDA-2007-P-0182-0005,FDA,FDA-2007-P-0182,Sanofi Aventis U.S. Inc. - Appendix A - Excerpt for Relative bioavailability study,Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-05-06T04:00:00Z,2008,5,,,2008-05-06T18:01:28Z,,0,0,090000648054c420
FDA-2007-P-0182-0003,FDA,FDA-2007-P-0182,sanofi aventis - Citizen Petition,Other,CP-Citizen Petition,2008-05-06T04:00:00Z,2008,5,2008-05-06T04:00:00Z,,2008-08-08T21:53:51Z,,0,0,090000648054c41d
FDA-2007-P-0182-0006,FDA,FDA-2007-P-0182,Sanofi Aventis U.S. Inc. - Detailed Statement re Abrika's Opinion,Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-05-06T04:00:00Z,2008,5,,,2008-05-06T18:01:29Z,,0,0,090000648054c423
FDA-2007-P-0182-0008,FDA,FDA-2007-P-0182,Sanofi Aventis U.S. Inc. - Reference,Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-05-06T04:00:00Z,2008,5,,,2008-05-06T18:01:30Z,,0,0,090000648054c426
FDA-2007-P-0182-0007,FDA,FDA-2007-P-0182,Sanofi Aventis U.S. Inc. - Appendix B - Excerpt from bioavailability study,Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-05-06T04:00:00Z,2008,5,,,2008-05-06T18:01:30Z,,0,0,090000648054c425
FDA-2007-P-0182-0004,FDA,FDA-2007-P-0182,Sanofi Aventis U.S. Inc. - Reference - Detailed Basis for BARs Paragraph IV Certification,Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-05-06T04:00:00Z,2008,5,,,2008-05-06T18:01:27Z,,0,0,090000648054c41e
FDA-2007-P-0182-0009,FDA,FDA-2007-P-0182,Sanofi Aventis U.S. Inc. - References - Published Materials,Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-05-06T04:00:00Z,2008,5,,,2008-05-06T18:01:31Z,,0,0,090000648054c462
FDA-2007-P-0182-0002,FDA,FDA-2007-P-0182,FDA Center for Drug and Evaluation Research Response to Sanofi Aventis - Letter,Other,LET-Letter,2007-12-04T05:00:00Z,2007,12,,,2008-07-15T23:43:46Z,,0,0,090000648042a706
FDA-2007-P-0182-0001,FDA,FDA-2007-P-0182,Acknowledgement Letter to Sanofi Aventis U.S. Inc.,Other,ACK-Acknowledgement Letter,2007-06-08T04:00:00Z,2007,6,,,2008-07-15T23:31:55Z,,0,0,090000648042a6f7